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Background: While symptoms of deficient emotional self-regulation (DESR) have been 
long associated with attention-deficit/hyperactivity disorder (ADHD), there has been limited 
investigation of this aspect of the clinical picture of the disorder. The main aim of this study 
was to examine the predictive utility of DESR in moderating the course of ADHD children 
into adolescence.
Methods: Subjects comprised 177 children with and 204 children without ADHD followed 
for an average of 4 years (aged 6–18 years at baseline, 54% male). Subjects were assessed with 
structured diagnostic interviews and measures of psychosocial functioning. DESR was defined 
by the presence (n = 79) or absence (n = 98) of Child Behavior Checklist (CBCL)-DESR profile 
(score $ 180 , 210 total of Attention, Aggression, and Anxious/Depressed subscales) at the 
baseline assessment.
Results: Of subjects with DESR at baseline, 57% had DESR at follow-up. Persistent ADHD 
was significantly associated with DESR at follow-up (χ2
(1) = 15.37, P , 0.001). At follow-up, 
ADHD + DESR subjects had significantly more comorbidities (z = 2.55, P = 0.01), a higher 
prevalence of oppositional defiant disorder (z = 3.01, P = 0.003), and more impaired CBCL 
social problems t-score (t(227) = 2.41, P = 0.02) versus ADHD subjects.
Conclusion: This work suggests that a positive CBCL-DESR profile predicts subsequent 
psychopathology and functional impairments in children with ADHD suggesting that it has the 
potential to help identify children with ADHD at high risk for compromised outcomes.
Keywords: attention-deficit/hyperactivity disorder, emotion, regulation, longitudinal, youth
Introduction
Although attention-deficit/hyperactivity disorder (ADHD) has been conceptualized 
as a disorder of deficient self-regulation,1 the DSM-IV (Diagnostic and Statistical 
Manual of Mental Disorders, 4th Edition, Text Revision)2 symptoms of the disorder 
have been limited to those of cognitive (inattention) and behavioral (hyperactivity/
impulsivity) deficits, leaving out deficient emotional self-regulation (DESR). DESR 
refers to: deficits in self-regulating the physiological arousal caused by strong emotions; 
  difficulties inhibiting inappropriate behavior in response to either positive or negative 
emotions; problems refocusing attention from strong emotions; and disorganization 
of coordinated behavior in response to emotional activation.3 DESR traits include low 
tolerance of frustration, impatience, quickness to anger, and being easily excited to 
emotional reactions. Although these traits may be a source of significant morbidity, 
there has been a paucity of research on the subject.3–6
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The symptoms of DESR should not be confused with the 
emotional symptoms of mood disorders. DESR differs from 
the persistent and severe irritability often seen in pediatric 
mood disorder.7 Unlike DESR, the abnormal mood of mood 
disorder is not defined by poor self-regulation and includes 
features that are not part of DESR (eg, the other mood criteria 
in DSM-IV).
We recently examined8 whether a unique profile of the 
Child Behavior Checklist (CBCL) would help identify DESR 
in children with ADHD. We defined DESR if a child had a 
sum of t scores of .180 but ,210 (between one and two 
standard deviations [SD] above the mean) on the Anxiety/
Depression, Aggression, and Attention scales of the CBCL 
(CBCL-DESR). This profile was selected because of its con-
ceptual congruence with the clinical concept of DESR and 
because its extreme (.210, more than 2 SD above the mean) 
form had been previously associated with severe forms of 
mood and behavioral dysregulation in children with ADHD.9 
We found that 44% of children with ADHD had a positive 
CBCL-DESR profile versus 2% of controls (P , 0.001). 
The CBCL-DESR profile was associated with elevated rates 
of anxiety and disruptive behavior disorders, as well as sig-
nificantly more impairment in emotional and interpersonal 
functioning. These findings suggested that the CBCL-DESR 
profile helped identify a subgroup of ADHD children with 
a psychopathological and functional profile consistent with 
the clinical concept of DESR. DESR remained associated 
with poorer psychosocial functioning even after controlling 
for comorbid disorders, suggesting that DESR may represent 
a burdensome source of morbidity in children with ADHD 
that is partially independent of comorbid disorders such as 
oppositional defiant disorder. Others have examined this 
CBCL-DESR profile but not using the cutoffs defined by 
our group. Ayer et al10 found that the profile was associated 
with lower functioning and child suicidal behavior. Althoff 
et al11 found cross-informant agreement of the profile and 
describe its association with suicidal thoughts and behaviors. 
However, more information is needed as to the prognostic 
significance of this profile.
New insights into the role that DESR plays in the clinical 
picture of ADHD would have important clinical and scien-
tific implications. Clinically, DESR could account for the 
frequent social interaction problems and impairments in 
several domains of major life activities that are commonly 
seen with ADHD and other disorders. If so, the assessment 
of DESR could be an important feature of child psychiatric 
assessment. Scientifically understanding the relationships 
between ADHD and DESR could provide new insight into 
the neural basis of emotional regulation separating cortical 
regulatory regions from limbic ones. It could also help 
identify genes associated with emotional dysregulation apart 
from those associated with other behavioral and cognitive 
features of psychopathology.
The main aim of this study was to assess the longitudinal 
course of DESR in ADHD children. To this end, we used 
longitudinal follow-up data from two identically designed 
large controlled studies of well characterized boys and girls 
with and without ADHD. We hypothesized that a positive 
CBCL-DESR profile will predict more psychopathology and 
poorer psychosocial functioning in children with ADHD 
at follow-up. To the best of our knowledge, this is the first 
investigation of this issue.
Materials and methods
Subjects
The methodology used in this study has been previously 
described.12,13 Briefly, subjects were derived from two iden-
tically designed lo  ngitudinal case-control family studies of 
ADHD. These studies recruited male and female subjects 
aged 6–18 years with (n = 140 boys, n = 140 girls) and without 
(n = 120 boys, n = 122 girls) DSM-III-R ADHD ascertained 
from pediatric and psychiatric clinics. Male subjects were 
assessed at baseline and at four-year follow-up while female 
subjects were assessed at baseline and at five-year follow-up. 
Potential subjects were excluded if they had been adopted or 
if their nuclear family was not available for study. We also 
excluded potential subjects if they had major sensorimotor 
handicaps (paralysis, deafness, blindness), psychosis, autism, 
inadequate command of the English language, or a Full Scale 
IQ less than 80. Parents and adult offspring provided written 
informed consent to participate, and parents also provided 
consent for offspring under the age of 18 years. Children and 
adolescents provided written assent to participate. The human 
research committee at Massachusetts General   Hospital 
approved this study.
Measures
Psychiatric assessments of probands younger than 
18 years relied on the Kiddie Schedule for Affective 
Disorders and Schizophrenia - Epidemiological Version 
  (KSADS-E).14,15 Subjects 18 years of age and older were 
assessed with the Structured Clinical Interview for DSM16,17 
(supplemented with modules from the K-SADS-E to assess 
childhood diagnoses). Diagnoses for this analysis were 
considered positive if full criteria were met within the past 
year of the assessment. We interviewed the mothers for all 
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subjects and directly interviewed subjects older than 12 years. 
We combined data from direct and indirect interviews by con-
sidering a diagnostic criterion positive if it was endorsed in 
either interview. Interviewers blind to all previous information 
about the child and family assessed mothers and children.
The interviewers had undergraduate degrees in psychol-
ogy and were extensively trained. Based on 500 assessments 
from interviews of children and adults, the median kappa 
coefficient for diagnoses was 0.98. Kappa coefficients for 
individual diagnoses included ADHD (0.88), cognitive dis-
order (1.0), major depression (1.0), mania (0.95), separation 
anxiety (1.0), agoraphobia (1.0), panic (0.95), and substance 
use disorder (1.0). We considered a disorder positive if DSM 
diagnostic criteria were unequivocally met.
A committee of board-certified child and adult psychia-
trists who were blind to the subject’s ADHD status, referral 
source, and all other data resolved diagnostic uncertainties. 
Diagnoses presented for review were considered positive 
only when the committee determined that diagnostic criteria 
were met to a clinically meaningful degree. We estimated 
the reliability of the diagnostic review process by computing 
kappa coefficients of agreement for clinician reviewers. For 
these diagnoses, the median reliability between individual 
clinicians and the review committee assigned diagnoses was 
0.87. Kappa coefficients for individual diagnoses included 
ADHD (1.0), conduct disorder (1.0), major depression (1.0), 
mania (0.78), separation anxiety (0.89), agoraphobia (0.80), 
panic (0.77), and substance use disorder (1.0).
All assessment personnel were blind to proband diagno-
sis (ADHD or control) and ascertainment site (psychiatric 
or pediatric). The diagnosis of major depression was made 
only if the depressive episode was associated with severe 
impairment.18,19 Since there are many anxiety disorders 
measured by our structured interviews, we aggregated them 
into a binary measure-coded positive if two or more anxiety 
disorders were endorsed, and negative otherwise. Two or more 
anxiety disorders previously provided a reasonable trade-
off between case identification and the false positive rate 
when compared against an independently defined “anxiety 
standard” in youth with ADHD.20 Psychoactive substance 
use disorder was defined as any alcohol abuse, alcohol 
dependence, substance abuse, or substance dependence. 
Total comorbidities were calculated as the number of up to 
six psychiatric disorders/categories (bipolar disorder, major 
depressive disorder, multiple anxiety disorders, oppositional 
defiant disorder, conduct/antisocial personality disorder, 
psychoactive substance use disorder) present at any time in 
the year before the structured interview.
Global functioning was assessed using the Global 
  Assessment of Functioning Scale.21 Psychosocial functioning 
was assessed using the Social Adjustment Inventory for 
Children and Adolescents (SAICA).22 The SAICA provides 
an evaluation of children’s functioning in school, in spare time 
activities, and with peers, siblings, and parents. A SAICA 
subscale is an average of 3–11 Likert items (eg, 1 = not a 
problem, 2 = mild problem, 3 = moderate problem, 4 = severe 
problem) from an area of social functioning. Family func-
tioning was defined using the Moos Family Environment 
Scale,23 which uses standard scores with a mean of 50 and 
SD of 10. Higher family conflict and lower family cohesion 
and expressiveness scores indicate poorer family   functioning. 
Socioeconomic status was measured using the five-point 
Hollingshead scale.24
Assessment of deficient emotional  
self-regulation
Assessment of DESR relied on the CBCL,25 completed at 
baseline and follow-up. A parent (usually the mother) of 
each participant completed the 1991 version of the Child 
Behavior Checklist for children aged 4–18 years. The CBCL 
is an affordable pencil and paper test completed by the child’s 
caregiver, requiring no administration by a physician or rater. 
The CBCL queries the parent about the child’s behavior in 
the past 6 months and aggregates this data into behavioral 
  problem t scores.25 A computer program calculates the 
t scores for each scale. Raw scores are converted to gender- 
and age-standardized scores (t scores having a mean of 50 
and a SD of 10). A minimum t score of 50 is assigned to 
scores that fall at midpoint percentiles of #50 on the syn-
drome scales to permit comparison of standardized scores 
across scales. DESR was defined as positive if the sum of 
the CBCL   Attention Problems, Aggressive Behavior, and 
Anxious-Depressed t scores was $180 and ,210. These 
  cutoff scores represent, on average, 1 SD (t score = 60) to 
2 SD (t score = 70) on each of the three selected CBCL 
subscales. Subjects with a sum of .210 on these CBCL 
subscales were excluded, because we previously showed that 
these subjects were at risk for developing bipolar disorder 
and associated impairments.9
Statistical analysis
We compared ADHD probands with and without DESR on 
baseline demographic characteristics using t-tests, Pearson’s 
Chi-square, or Wilcoxon rank-sum tests. The one-year preva-
lence rates of baseline and follow-up psychiatric disorders 
were compared using logistic regression, and controlling for 
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demographic confounders. Linear regression was used to test 
continuous variables (eg, Global Assessment of Functioning 
Scale) and negative binomial regression was used to test 
count variables (eg, total number of comorbidities). All tests 
were two-tailed with alpha set at 0.05.
Results
Of 280 subjects with ADHD and 242 subjects without 
ADHD at baseline, 242 and 229, respectively, had CBCL 
data (  Figure 1). Of the 242 ADHD subjects, 45 were dropped 
because they had an attention problems + aggressive behav-
ior + an anxious-depressed (AAA) score of .210 at base-
line. Of the 229   control subjects, five were dropped because 
they met criteria for DESR. Of the remaining 197 ADHD 
subjects and 224 control subjects, 177 (100 boys, 77 girls) 
and 204 (105 boys, 99 girls),   respectively, had follow-up 
data. The mean follow-up time was 4.4 years (SD 1.1 years, 
range 3–9 years).
Of the 177 ADHD subjects with follow-up data, 
  119 subjects had CBCL data at the four-year follow-up. The 
kappa for DESR between the baseline and four-year follow-
up assessments was 0.29 (P , 0.001), 57% of   subjects with 
DESR at baseline also had DESR at follow-up (sensitivity, 
33/58), 72% of subjects without DESR at baseline did not have 
DESR at follow-up (specificity, 44/61), the positive predictive 
value was 66% (33/50), and the negative predictive value was 
64% (44/69). The intraclass correlation of the continuous AAA 
score between baseline and follow-up was 0.47 (P , 0.001). 
Persistent ADHD (full or subthreshold diagnosis in the last 
month) was significantly associated with DESR at follow-up 
(0/18 with remittent ADHD had DESR compared with 50/101 
with persistent ADHD had DESR, χ2
(1) = 15.37, P , 0.001).
Comparisons were made between controls (n = 204) 
versus ADHD subjects with (ADHD + DESR, n = 79) and 
without DESR at baseline (ADHD, n = 98). Subjects used 
for this analysis (n = 381) did not significantly differ from 
subjects lost to follow-up (n = 40) on group status (P = 0.64), 
gender/study (P = 0.65), age (P = 0.58), socioeconomic status 
(P = 0.16), or ascertainment source (P = 0.69).
Sociodemographic characteristics
There were no differences between groups on gender, socio-
economic status, family intactness, or ascertainment source 
(Table 1). The ADHD + DESR group was significantly 
younger than controls. Therefore, all analyses controlled 
for age.
Psychopathology at the 4-year  
follow-up
At the adolescent follow-up, both ADHD groups had signifi-
cantly higher 1-year prevalence rates of bipolar (z = 3.89, 
P , 0.001), major depressive (z = 4.59, P , 0.001), mul-
tiple anxiety (z = 4.27, P , 0.001), and conduct/antisocial 
personality (z = 3.34, P = 0.001) disorders compared with 
controls (Figure 2). In addition, the ADHD + DESR group 
continued to have significantly more total comorbidities at 
follow-up compared with the ADHD and control groups (1.4 
versus 0.9, z = 2.55, P = 0.01 and 1.4 versus 0.3, z = 8.61, 
P , 0.001, respectively) as well as a significantly higher one-
year prevalence of oppositional defiant disorder (z = 3.01, 
P = 0.003 and z = 7.28, P , 0.001, respectively, Figure 2D). 
DESR was not significantly associated with mood disorders 
at baseline or follow-up (all P . 0.05).
At follow-up, both ADHD groups continued to have 
higher thought problems and delinquent behavior t scores 
at follow-up compared with the controls (ADHD + DESR: 
t(227) = 5.38, ADHD: t(227) = 3.79, both P , 0.001). ADHD + 
DESR subjects continued to have a more impaired social 
280 ADHD
242 controls
242 ADHD
229 controls
197 ADHD
229 controls
197 ADHD
224 controls
177 ADHD
204 controls
Recruited at baseline •
Missing CBCL: 38 ADHD, 13 controls •
CBCL-AAA score ≥ 210: 45 ADHD, 0 controls •
5 controls met criteria for DESR •
Lost to follow-up: 20 ADHD, 20 controls •
Final sample: controls (n = 204), ADHD (n = 98), ADHD + DESR (79) •
Figure 1 Participant flow chart.
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; CBCL, Child Behavior Checklist; CBCL-AAA, Anxiety/Depression, Aggression, and Attention subscales of 
the Child Behavior Checklist; DESR, deficient emotional self-regulation.
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problems t score compared with the ADHD and control 
groups (t(227) = 2.41, P = 0.02 and t(227) = 7.68, P , 0.001, 
respectively, Figure 3).
Psychosocial functioning
Figure 4A shows that the ADHD + DESR group continued to 
have poorer global functioning than the ADHD and control 
groups at follow-up (t(377) = −3.71, P , 0.001 and t(377) = −15.14, 
P , 0.001, respectively). While DESR was associated with 
significantly poorer social adjustment at baseline (t(365) = 4.38, 
P , 0.001), this no longer held true at follow-up due to the 
more impaired Social adjustment inventory for children and 
adolescents (SAICA) score in the ADHD group at follow-up 
(t(166) = 0.75, P = 0.45, Figure 4B). The ADHD + DESR group 
Table 1 Demographics, mean standard deviation or n (%)
Mean ± SD Test statistic P-value
Controls ADHD ADHD + DESR
n = 204 n = 98 n = 79
Age at baseline, years 11.8 ± 3.3 11.2 ± 3.2 10.6 ± 3.0* F(2,378) = 4.25 P = 0.02
Age at follow-up, years 16.3 ± 3.5 15.6 ± 3.5 15.1 ± 3.3* F(2,378) = 3.81 P = 0.02
Socioeconomic status 1.6 ± 0.7 1.8 ± 1.0 1.8 ± 0.9 χ2
(2) = 3.69 P = 0.16
n (%)
Gender (male) 105 (51) 57 (58) 43 (54) χ2
(2) = 1.21 P = 0.55
Race/ethnicity Fisher’s exact P = 0.57
  African American 7 (3) 1 (1) 1 (1)
  Asian American 3 (1) 0 (0) 0 (0)
  Caucasian 191 (94) 97 (99) 77 (97)
  Latino 3 (1) 0 (0) 1 (1)
intact family 169 (83) 71 (72) 62 (78) χ2
(2) = 4.39 P = 0.11
Notes: *P # 0.01 versus controls.
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; DESR, deficient emotional self-regulation.
Controls ADHD ADHD + DESR Controls ADHD ADHD + DESR
Controls ADHD ADHD + DESR Controls ADHD ADHD + DESR
Controls ADHD ADHD + DESR Controls ADHD ADHD + DESR
Baseline Follow-up Baseline Follow-up
Baseline Follow-up Baseline Follow-up
Baseline Follow-up Baseline Follow-up
AB
CD
EF
Bipolar disorder
Multiple (≥2) anxiety disorders
Conduct/antisocial personality disorder Psychoactive substance use disorder
Major depressive disorder
Oppositional defiant disorder
A A
A
A
A A
A
A A
A
A
A
A
AB AB
AB
AB
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25
20
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5
0
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%
Figure 2 One-year prevalence rates of disorders at baseline and follow-up by DESR status. (A) bipolar disorder, (B) major depressive disorder, (C) multiple ($2) anxiety 
disorders, (D) oppositional defiant disorder, (E) conduct/antisocial personality disorder, and (F) psychoactive substance use disorder.
Notes: A: P < 0.05 vs controls, B: P < 0.05 vs ADHD.
Abbreviation: ADHD, attention-deficit/hyperactivity disorder; DESR, deficient emotional self-regulation.
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had poorer Family Environment Scale scores at baseline 
(expression: t(372) = 2.35, P = 0.02; conflict: t(372) = 2.62, 
P = 0.009; cohesion: t(372) = 2.05, P = 0.04) and follow-up 
(expression: t(241) = 1.33, P = 0.18; conflict: t(241) = 0.96, P = 0.34; 
cohesion: t(242) = 1.66, P = 0.10) compared with the ADHD 
group, although the differences attained statistical significance 
only at baseline (Figure 5). DESR was not associated with edu-
cational functioning (extra tutoring, placement in special class, 
repeated grade) at baseline or follow-up (all P . 0.30).
Discussion
Our a priori definition of DESR based on moderate (.1 
and ,2 SD) elevations of CBCL-DESR identified a clini-
cally meaningful subgroup of ADHD children at high risk for 
long-term morbidity and dysfunction consistent with current 
conceptualizations of DESR. The CBCL-DESR profile was 
associated at the follow-up assessment into adolescent years 
with higher rates of persistence of ADHD, more psychiatric 
comorbidity, more impaired scores on the Social Problems 
CBCL scale, as well as more impaired ratings of the Global 
Assessment of Functioning Scale. These findings suggest 
that the CBCL-DESR profile can help identify a clinically 
meaningful subgroup of children with ADHD with long-term 
compromised outcomes.
The finding that 57% of subjects with DESR at baseline 
also had DESR at follow-up suggests that DESR is a largely 
persistent trait (intraclass correlation of the continuous AAA 
score between baseline and follow-up was 0.47). Also note-
worthy is the finding that DESR was predictive of a persis-
tent course of ADHD; 50% of ADHD youth with persistent 
ADHD had DESR versus 0% in those without.
At the adolescent follow-up, ADHD + DESR subjects 
continued to have significantly more mean number of comor-
bidities compared with ADHD and control subjects as well 
64
AB
AB
AB
AB
AB AB
A
A
A A
A
A
A
A
A
A A
62
60
58
56
54
52
50
62
60
58
56
54
52
50
Withdrawn Somatic
problems
Social
problems
Thought
problems
Delinquent
behavior
Withdrawn Somatic
problems
Social
problems
Thought
problems
Delinquent
behavior
Controls ADHD ADHD + DESR
Controls ADHD ADHD + DESR
A
B Follow-up CBCL
Mean
score
Mean
score
Baseline CBCL
Figure 3 CBCL scales not used in deficient emotional self-regulation definition. (A) Baseline CBCL and (B) follow-up CBCL.
Notes: A: P < 0.05 vs controls, B: P < 0.05 vs ADHD.
Abbreviation: ADHD, attention-deficit/hyperactivity disorder; CBCL, Child Behavior Checklist; DESR, deficient emotional self-regulation.
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as a significantly higher one-year prevalence of oppositional 
defiant disorder. These findings are congruent with those 
derived from analysis of the follow-up CBCL data showing 
more social problems associated with DESR in children with 
ADHD growing up. Although social functioning as measured 
by the SAICA was significantly associated with DESR at 
baseline and not at follow-up, subjects with DESR had the 
same high overall SAICA score at follow-up as they did at 
baseline (Figure 4B).
Also congruent with the psychopathological findings are 
those showing that children with ADHD + DESR continued 
to have poorer global functioning than the ADHD and   control 
groups at follow-up. These findings are consistent with those 
of Whalen and Henker,26 who found that emotional dysregula-
tion in ADHD children disrupted the smoothness, reciprocity, 
and cooperative activities involved in peer relationships and 
with the suggestion by Barkley3 that DESR might account for 
a significant portion of the social dysfunction documented 
in ADHD. Several diagnostic and functioning measures 
that were associated with DESR at baseline were no lon-
ger significantly different at follow-up, including multiple 
anxiety disorders, conduct/antisocial personality disorder, 
several CBCL scales, SAICA, and Family Environment 
Scale. Therefore, the CBCL-DESR profile appears better at 
identifying children with ADHD with more extreme concur-
rent impairments than at identifying children at risk for future 
impairments. The fact that nearly half (43%) of the children 
with DESR at baseline no longer had DESR at follow-up 
may explain the somewhat weaker findings at follow-up. 
DESR was not associated with substance use disorders at 
baseline or follow-up. Because a substantial proportion of 
this sample had not yet entered the age of risk for substance 
use disorders, future studies should seek to confirm this lack 
of association.
Our longitudinal findings that children with ADHD with 
the CBCL-DESR profile were at significantly increased risk 
for oppositional defiant disorder but not for depression and 
bipolar disorder stand in contrast with findings of increased 
risks for these mood disorders associated with the CBCL-
Pediatric Bipolar profile.9 This latter profile requires very 
abnormal (2 SD) scores on the same scales of Anxiety/
Depression, Aggression, and Attention of the CBCL used 
85
80
75
70
A
A
A
A
A
AB AB
AB
65
60
55
50
2.2
2.1
2
1.9
1.8
1.7
1.6
1.5
Baseline Follow-up
Baseline
Mean
SAICA
score
Mean
GAF
score
Social adjustment inventory for
children and adolescents (SAICA)
Global assessment of functioning (GAF)
Follow-up
A
B
Controls
ADHD
ADHD + DESR
Controls
ADHD
ADHD + DESR
Figure 4 Psychosocial functioning by deficient emotional self-regulation. (A) Global Assessment of Functioning and (B) Social Adjustment inventory for Children and 
Adolescents.
Notes: A: P < 0.001 vs controls, B: P < 0.001 vs ADHD.
Abbreviation: ADHD, attention-deficit/hyperactivity disorder; DESR, deficient emotional self-regulation.
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to define the CBCL-DESR profile. These nonoverlapping 
profile findings between the high (2 SD) and the intermedi-
ate (1 SD) CBCL profiles (used to define DESR) support 
the hypotheses that these are mutually exclusive profiles 
that identify different clinical entities, with the severe profile 
likely identifying the extreme mood dysregulation associated 
with mood disorder, while the intermediate one is limited to 
deficient emotional self-regulation.
While both DESR and mood disorders involve emotional 
dysregulation, these constructs are substantially different 
clinically. The cardinal feature of mood disorders is the 
experience of strong emotions, not their self-regulation, 
the hallmark of DESR. Children who fulfilled the CBCL-
DESR criteria were not more likely to have bipolar disorder 
or major depression or to have been hospitalized than other 
children with ADHD. In this regard, our data support the 
utility of the CBCL in defining DESR as a substantially 
different clinical entity than the CBCL-Juvenile Bipolar 
profile used to identify children at high risk for pediatric 
bipolar disorder. In fact, a comprehensive literature review2 
documents numerous studies in which children and adults 
with ADHD are highly likely to manifest DESR character-
ized by “low frustration tolerance, impatience, quickness 
to anger, and being easily excited to emotional reactions 
more generally”.
Our findings need to be viewed in light of some method-
ological limitations. Although our rate of retention was high 
(90%), our findings may have been affected by attrition bias. 
The large age range of our sample makes it difficult to assess 
any developmentally sensitive outcomes.
Our definition of emotional dysregulation relied on eleva-
tions in three CBCL clinical scales (A-A-A). Others have 
used this scale without cutoffs to measure dysregulated mood, 
attention, and behavior pathology across DSM-IV   diagnoses.10 
One limitation of our CBCL definition of DESR is that, 
because it includes the Attention Problems Scale, which is 
known to be associated with ADHD, it may simply define a 
more severe form of ADHD, rather than a categorically differ-
ent form of ADHD. In fact, our previous examination7 showed 
that DESR was associated with greater ADHD-associated 
impairment. On the other hand, our prior family studies of 
DESR suggest that ADHD + DESR is distinct from a familial 
perspective.4,27 Although we selected the CBCL-DESR profile 
from ongoing conceptualizations of DESR in the literature 
(most fully articulated by Barkley2) indexing deficits in 
self-regulating cognition and inhibiting behavior caused by 
strong emotions, we do not know whether our results would 
be replicated if other methods were used to define DESR. 
Investigating continuous measures or measures that do not 
have symptom overlap with other psychiatric diagnoses may 
help our understanding of DESR.
For example, Gioia et al28 reported that children with 
ADHD had higher ratings on the Behavior Rating Inventory 
of Executive Function (BRIEF) Emotional Control subscale 
compared with healthy children. However, since these authors 
did not report correlations of their BRIEF-defined DESR 
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Figure 5 Current (last month) Family Environment Scale. (A) Expression, (B) conflict, and (C) cohesion.
Notes: A: P < 0.001 vs controls, B: P < 0.001 vs ADHD.
Abbreviation: ADHD, attention-deficit/hyperactivity disorder; DESR, deficient emotional self-regulation; FES, Family Environment Scale.
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(beyond impulsivity), it is unclear whether the BRIEF-
Emotional Control Scale captures the same phenomenology 
as the CBCL-DESR profile. On the other hand, the validity 
of our construct of CBCL-DESR is supported by face valid-
ity, the consistency of the constituent symptoms with other 
definitions of DESR, its expression across a wide range of 
comorbid disorders and elevations of clinical scales, and 
its association with significant impairments beyond those 
accounted for by ADHD. Nevertheless, further research is 
needed to evaluate other definitions of DESR to determine its 
optimal definition. Because our sample was clinically referred 
and primarily Caucasian, our findings may not generalize to 
community samples and other ethnic groups.
Conclusion
Despite these considerations, these longitudinal findings 
indicate that intermediate (.1 and ,2 SD) scores on the 
Anxiety/Depression, Attention and Aggression CBCL sub-
scales can help identify a clinically meaningful subgroup of 
children with ADHD at high risk for more psychopathology 
and poorer functioning than other children with ADHD. 
These findings suggest that the CBCL-DESR profile may 
aid in the identification of children with deficient emotional 
regulation within and without the context of ADHD at high 
risk for compromised outcomes. Systematic efforts should 
be undertaken to determine the pharmacological or psycho-
logical interventions to best prevent these poor outcomes in 
children with ADHD and DESR.
Disclosure
JB is currently receiving research support from the following 
sources: Elminda, Janssen, McNeil, and Shire. In 2011, JB 
gave a single unpaid talk for Juste Pharmaceutical Spain, 
received honoraria from the MGH Psychiatry Academy for 
a tuition-funded continuing medical education course, and 
received an honorarium for presenting at an international sci-
entific conference on ADHD. He also received an honorarium 
from Cambridge University Press for a chapter publication. 
JB received departmental royalties from a copyrighted rat-
ing scale used for ADHD diagnoses, paid by Eli Lilly, Shire 
and AstraZeneca; these royalties are paid to the Department 
of Psychiatry at MGH. In 2010, JB received a speaker’s fee 
from a single talk given at Fundación Dr Manuel Camelo AC 
in Monterrey Mexico. JB provided single consultations for 
Shionogi Pharma Inc and Cipher Pharmaceuticals Inc; the 
honoraria for these consultations were paid to the Department 
of Psychiatry at the MGH. JB received honoraria from the 
MGH Psychiatry Academy for a tuition-funded continuing 
medical education course. In 2009, JB received a speaker’s 
fee from the following sources: Fundacion Areces (Spain), 
Medice Pharmaceuticals (Germany), and the Spanish Child 
Psychiatry Association. In previous years, JB has received 
research support, consultation fees, or speaker’s fees for/
from the following additional sources: Abbott, Alza, 
  AstraZeneca, Boston University, Bristol Myers Squibb, 
Celltech, Cephalon, Eli Lilly and Co, Esai, Forest, Glaxo, 
Gliatech, Hastings Center, Janssen, McNeil, Merck, MMC 
Pediatric, NARSAD, NIDA, New River, NICHD, NIMH, 
Novartis, Noven, Neurosearch, Organon, Otsuka, Pfizer, 
Pharmacia, Phase V Communications, Physicians Academy, 
The Prechter Foundation, Quantia Communications, Reed 
Exhibitions, Shire, The Stanley Foundation, UCB Pharma 
Inc, Veritas, and Wyeth.
TS has received research support from the following 
sources: Shire Laboratories Inc, Cephalon, Eli Lilly and 
Company, Glaxo-Smith Kline, Janssen, McNeil Pharma-
ceutical, Novartis Pharmaceuticals, Pfizer, and NIMH. 
TS has been a speaker or on a speaker’s bureau for the 
following pharmaceutical companies: Shire Laboratories 
Inc, Eli Lilly and Company, Glaxo-Smith Kline, Janssen, 
McNeil Pharmaceutical, and Novartis Pharmaceuticals. 
TS has been an advisor or on an advisory board for the 
following pharmaceutical companies: Shire Laboratories 
Inc, Cephalon, Eli Lilly and Company, Glaxo-Smith Kline, 
Janssen, McNeil Pharmaceutical, Novartis Pharmaceuticals, 
and Pfizer. TS receives research support from royalties and 
licensing fees on copyrighted ADHD scales through MGH 
Corporate Sponsored Research and Licensing. TS has a US 
patent application pending (Provisional Number 61/233,686), 
through MGH corporate licensing, on a method to prevent 
stimulant abuse.
CBHS has received research support from Abbott, Alza, 
Cephalon, Eli Lilly, the Hilda and Preston Davis Foundation, 
McNeil, Merck, New River, National Institutes of Health, 
Organon, Pfizer, Shire, and Takeda; has received support from 
Janssen-Ortho, McNeil, Novartis, and Shire for speaking and 
other educational activities; and has been a consultant/advisor 
for McNeil, Shire, Somaxon, and Takeda. CBHS has also 
received honoraria from Reed Medical Education (a logistics 
collaborator for the MGH Psychiatry Academy). Commercial 
entities supporting the MGH Psychiatry Academy are listed 
on the academy’s web site, http://www.mghcme.org.
In the past year, SVF received consulting income and 
research support from Shire and Alcobra and research 
support from the National Institutes of Health. In   previous 
years, he received consulting fees or was on advisory 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
275
Longitudinal course of DESRNeuropsychiatric Disease and Treatment
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journal
Neuropsychiatric Disease and Treatment is an international, peer-
reviewed journal of clinical therapeutics and pharmacology focusing 
on concise rapid reporting of clinical or pre-clinical studies on a 
range of neuropsychiatric and neurological disorders. This journal 
is indexed on PubMed Central, the ‘PsycINFO’ database and CAS.   
The manuscript management system is completely online and includes 
a very quick and fair peer-review system, which is all easy to use. Visit 
http://www.dovepress.com/testimonials.php to read real quotes from 
published authors.
Neuropsychiatric Disease and Treatment 2012:8
boards or   participated in continuing medical education 
programs sponsored by: Shire, McNeil, Janssen, Novartis, 
Pfizer and Eli Lilly. SVF receives royalties from books 
published by Guilford Press (Straight Talk about Your 
Child’s Mental Health) and Oxford University Press 
(Schizophrenia: The Facts). 
CP, LH, and KOC report no conflict of interest in this 
work. This manuscript was supported in part by grants to JB 
from the National Institutes of Health (R01 HD36317, R01 
MH50657) and to TS from Shire Pharmaceuticals.
References
  1.  Barkley RA. Behavioral inhibition, sustained attention, and executive 
functions: constructing a unifying theory of ADHD. Psychol Bull. 
1997;121(1):65–94.
  2.  American Psychiatric Association. Diagnostic and Statistical Manual 
of Mental Disorders: DSM-IV-TR. 4th ed, text revision. Washington, 
DC: American Psychiatric Association; 2000.
  3.  Barkley RA. Deficient emotional self-regulation: a core component of 
attention-deficit/hyperactivity disorder. Journal of ADHD and Related 
Disorders. 2010;1(2):5–37.
  4.  Surman CB, Biederman J, Spencer T, et al. Deficient emotional self 
regulation and adult attention deficit hyperactivity disorder: a family 
risk analysis. Am J Psychiatry. 2011;168(6):617–623.
  5.  Reimherr FW, Marchant BK, Williams ED, Strong RE, Halls C, Soni P. 
Personality disorders in ADHD Part 3: Personality disorder, social 
adjustment, and their relation to dimensions of adult ADHD. Ann Clin 
Psychiatry. 2010;22(2):103–112.
  6.  Jensen SA, Rosen LA. Emotional reactivity in children with attention-
deficit/hyperactivity disorder. J Atten Disord. 2004;8(2):53–61.
  7.  Wozniak J. Recognizing and managing bipolar disorder in children.   
J Clin Psychiatry. 2005;66 Suppl 1:18–23.
  8.  Spencer TJ, Faraone SV, Surman CB, et al. Toward defining defi-
cient emotional self-regulation in children with attention-deficit/ 
hyperactivity disorder using the Child Behavior Checklist: a controlled 
study. Postgrad Med. 2011;123(5):50–59.
  9.  Biederman J, Petty CR, Monuteaux MC, et al. The child behavior 
  checklist-pediatric bipolar disorder profile predicts a subsequent 
diagnosis of bipolar disorder and associated impairments in ADHD 
youth growing up: a longitudinal analysis. J Clin Psychiatry. 
2009;70(5):732–740.
  10.  Ayer L, Althoff R, Ivanova M, et al. Child Behavior Checklist   Juvenile 
Bipolar Disorder (CBCL-JBD) and CBCL Posttraumatic Stress 
  Problems (CBCL-PTSP) scales are measures of a single dysregulatory 
syndrome. J Child Psychol Psychiatry. 2009;50(10):1291–1300.
  11.  Althoff RR, Rettew DC, Ayer LA, Hudziak JJ. Cross-informant agree-
ment of the Dysregulation Profile of the Child Behavior Checklist. 
Psychiatry Res. 2010;178(3):550–555.
  12.  Biederman J, Faraone SV , Mick E, et al. Clinical correlates of ADHD in 
females: findings from a large group of girls ascertained from pediatric 
and psychiatric referral sources. J Am Acad Child Adolesc Psychiatry. 
1999;38(8):966–975.
  13.  Biederman J, Faraone S, Milberger S, et al. A prospective 4-year follow-
up study of attention-deficit hyperactivity and related disorders. Arch 
Gen Psychiatry. 1996;53(5):437–446.
  14.  Orvaschel H. Psychiatric interviews suitable for use in research 
with   children and adolescents. Psychopharmacol Bull. 1985;21(4): 
737–745.
  15.  Orvaschel H. Schedule for Affective Disorder and Schizophrenia for 
School-Age Children Epidemiologic Version. 5th ed. Fort Lauderdale, 
FL: Nova Southeastern University, Center for Psychological Studies; 
1994.
  16.  Spitzer RL, Williams JB, Gibbon M, First MB. Structured Clinical 
Interview for DSM-III-R: Non-Patient Edition (SCID-NP, Version 1.0). 
Washington, DC: American Psychiatric Press; 1990.
  17.  First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview 
for DSM-IV Axis I Disorders. Washington, DC: American Psychiatric 
Press; 1997.
  18.  Gershon ES, Hamovit J, Guroff JJ, et al. A family study of schizoaffec-
tive, bipolar I, bipolar II, unipolar, and normal control probands. Arch 
Gen Psychiatry. 1982;39(10):1157–1167.
  19.  Weissman MM, Leckman JF, Merikangas KR, Gammon GD, 
Prusoff BA. Depression and anxiety disorders in parents and   
children: Results from the Yale Family Study. Arch Gen Psychiatry. 
1984;41(9):845–852.
  20.  Mennin D, Biederman J, Mick E, Faraone SV. Towards defining   
a meaningful anxiety phenotpye for research in ADHD children. J Atten 
Disord. 2000;3(4):192–199.
  21.  Association AP. DSM-IV Sourcebook. Volume 1. Washington, DC: 
American Psychiatric Association; 1994.
  22.  John K, Gammon GD, Prusoff BA, Warner V . The Social   Adjustment 
Inventory for Children and Adolescents (SAICA): Testing of a new 
semistructured interview. J Am Acad Child Adolesc Psychiatry. 
1987;26(6):898–911.
  23.  Moos RH, Moos BS. Manual for the Family Environment Scale. Palo 
Alto, CA: Consulting Psychologists Press; 1974.
  24.  Hollingshead AB. Four Factor Index of Social Status. New Haven, CT: 
Yale Press; 1975.
  25.  Achenbach TM. Manual for the Child Behavior Checklist/4-18 and the 
1991 Profile. Burlington, VT: University of Vermont, Department of 
Psychiatry; 1991.
  26.  Whalen CK, Henker B. The social profile of attention-deficit   hyperactivity 
disorder. Child Adolesc Psychiatr Clin N Am. 1992;1(2):395–410.
  27.  Biederman  J,  Spencer T,  Lomedico A,  Day  H,  Petty  CR,   
Faraone SV . Deficient emotional self-regulation and pediatric attention 
deficit hyperactivity disorder: a family risk analysis. Psychol Med. 
2012;42(3):639–646.
  28.  Gioia GA, Isquith PK, Guy SC, Kenworthy L. Brief Behavior Rating 
Inventory of Executive Function: Manual. Lutz, FL: Psychological 
Assessment Resources; 2000.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
276
Biederman et al